Loading...
Loading...
  • Investor's Business Dailylast year

    Superbugs Turn Big Pharma, Gov't Focus To Antibiotics

    Late last month, the Obama administration rolled out a five-point plan to combat drug-resistant bacteria, which it said causes 2 million infections and 23,000 deaths in the U.S. alone every year. A report ...

  • GuruFocus.comlast year

    Mario Gabelli's Top 5 Stock Picks

    Mario Gabelli (Trades, Portfolio) is the founder of GAMCO Investors, a firm with $49.9 billion in assets under management across a range of funds.

  • Market Realistlast year

    Farallon Capital Starts New Position in Cubist Pharmaceuticals

    In December, the FDA approved Zerbaxa, Cubist's antibiotic that combats urinary tract infections and intra-abdominal infections in adults around the world.